Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2006 | 1 |
2008 | 1 |
2010 | 1 |
2017 | 1 |
2022 | 1 |
2024 | 1 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Targeted therapy in older women with breast cancer - What's the target?
Eur J Surg Oncol. 2017 May;43(5):944-948. doi: 10.1016/j.ejso.2017.01.014. Epub 2017 Feb 3.
Eur J Surg Oncol. 2017.
PMID: 28215732
Review.
Prevalence of Self-Reported Venous Thromboembolism and Cardiovascular Risk Factors in Patients with Ulcerative Colitis: The GETAID FOCUS Study.
Guillo L, Amiot A, Serrero M, Altwegg R, Roblin X, Atanasiu C, Buisson A, Le Berre C, Reenaers C, Gornet JM, Laharie D, Abitbol V, Biron A, Caron B, Nancey S, Chupin A, Blain A, Vuitton L, Caillo L, Kirchgesner J, Nachury M, Peyrin-Biroulet L; FOCUS Study Group.
Guillo L, et al.
Dig Dis Sci. 2022 Sep;67(9):4525-4532. doi: 10.1007/s10620-022-07445-4. Epub 2022 Mar 4.
Dig Dis Sci. 2022.
PMID: 35246801
Free article.
Item in Clipboard
Ranibizumab combined with verteporfin photodynamic therapy in neovascular age-related macular degeneration: year 1 results of the FOCUS Study.
Heier JS, Boyer DS, Ciulla TA, Ferrone PJ, Jumper JM, Gentile RC, Kotlovker D, Chung CY, Kim RY; FOCUS Study Group.
Heier JS, et al.
Arch Ophthalmol. 2006 Nov;124(11):1532-42. doi: 10.1001/archopht.124.11.1532.
Arch Ophthalmol. 2006.
PMID: 17101999
Clinical Trial.
Item in Clipboard
NEDA-3 achievement in early highly active relapsing remitting multiple sclerosis patients treated with Ocrelizumab or Natalizumab.
Signoriello E, Signori A, Lus G, Romano G, Marfia GA, Landi D, Napoli F, D' Amico E, Zanghí A, Di Filippo PS, Caliendo D, Carotenuto A, Spiezia AL, Fantozzi R, Centonze D, Lucchini M, Mirabella M, Cocco E, Frau J, Maniscalco GT, Di Battista ME, Foschi M, Surcinelli A, Bonavita S, Abbadessa G, Pasquali L, Di Gregorio M, Ferrò MT, Sormani MP, Schiavetti I; ON focus study group.
Signoriello E, et al.
Mult Scler Relat Disord. 2024 Apr 6;87:105594. doi: 10.1016/j.msard.2024.105594. Online ahead of print.
Mult Scler Relat Disord. 2024.
PMID: 38718748
Free article.
Item in Clipboard
Ranibizumab combined with verteporfin photodynamic therapy in neovascular age-related macular degeneration (FOCUS): year 2 results.
Antoszyk AN, Tuomi L, Chung CY, Singh A; FOCUS Study Group.
Antoszyk AN, et al.
Am J Ophthalmol. 2008 May;145(5):862-74. doi: 10.1016/j.ajo.2007.12.029. Epub 2008 Mar 5.
Am J Ophthalmol. 2008.
PMID: 18321465
Clinical Trial.
Item in Clipboard
Health-related quality of life in relapsing remitting multiple sclerosis patients during treatment with glatiramer acetate: a prospective, observational, international, multi-centre study.
Jongen PJ, Lehnick D, Sanders E, Seeldrayers P, Fredrikson S, Andersson M, Speck J; FOCUS study group.
Jongen PJ, et al.
Health Qual Life Outcomes. 2010 Nov 15;8:133. doi: 10.1186/1477-7525-8-133.
Health Qual Life Outcomes. 2010.
PMID: 21078142
Free PMC article.
Item in Clipboard
Cite
Cite